Home > Publications database > Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer > print

001     293788
005     20241015142402.0
024 7 _ |a 10.1021/acs.jmedchem.4c01325
|2 doi
024 7 _ |a 0095-9065
|2 ISSN
024 7 _ |a 0022-2623
|2 ISSN
024 7 _ |a 1520-4804
|2 ISSN
024 7 _ |a 1943-2992
|2 ISSN
024 7 _ |a altmetric:168682849
|2 altmetric
024 7 _ |a pmid:39331123
|2 pmid
037 _ _ |a DKFZ-2024-01946
082 _ _ |a 610
100 1 _ |a Mowat, Jeffrey
|b 0
245 _ _ |a Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer
260 _ _ |a Washington, DC
|c 2024
|b ACS
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1728994999_8009
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #LA:D220#LA:D200# / 2024 Oct 10;67(19):17429-17453
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Carretero, Rafael
|0 P:(DE-He78)86723b26e79aa190a6c7294651a80986
|b 1
|u dkfz
700 1 _ |a Leder, Gabriele
|b 2
700 1 _ |a Aiguabella Font, Nuria
|b 3
700 1 _ |a Neuhaus, Roland
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Berndt, Sandra
|b 5
700 1 _ |a Günther, Judith
|0 0000-0001-5794-8984
|b 6
700 1 _ |a Friberg, Anders
|0 0000-0002-3912-8162
|b 7
700 1 _ |a Schäfer, Martina
|b 8
700 1 _ |a Briem, Hans
|0 0000-0002-8498-2448
|b 9
700 1 _ |a Raschke, Marian
|b 10
700 1 _ |a Miyatake Ondozabal, Hideki
|0 0000-0002-0199-9544
|b 11
700 1 _ |a Buchmann, Bernd
|b 12
700 1 _ |a Boemer, Ulf
|b 13
700 1 _ |a Kreft, Bertolt
|b 14
700 1 _ |a Hartung, Ingo V.
|b 15
700 1 _ |a Offringa, Rienk
|0 P:(DE-He78)81ae96953d6149e4307057d71a190019
|b 16
|e Last author
|u dkfz
773 _ _ |a 10.1021/acs.jmedchem.4c01325
|g p. acs.jmedchem.4c01325
|0 PERI:(DE-600)1491411-6
|n 19
|p 17429-17453
|t Journal of medicinal chemistry
|v 67
|y 2024
|x 0095-9065
909 C O |p VDB
|o oai:inrepo02.dkfz.de:293788
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)86723b26e79aa190a6c7294651a80986
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)81ae96953d6149e4307057d71a190019
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1200
|2 StatID
|b Chemical Reactions
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1210
|2 StatID
|b Index Chemicus
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J MED CHEM : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J MED CHEM : 2022
|d 2023-10-21
920 2 _ |0 I:(DE-He78)D220-20160331
|k D220
|l DKFZ -Bayer Healthcare Joint
|x 0
920 2 _ |0 I:(DE-He78)D200-20160331
|k D200
|l Molekulare Grundlagen Gastrointestinaler Tumoren
|x 1
920 1 _ |0 I:(DE-He78)D220-20160331
|k D220
|l DKFZ -Bayer Healthcare Joint
|x 0
920 1 _ |0 I:(DE-He78)D200-20160331
|k D200
|l Molekulare Grundlagen Gastrointestinaler Tumoren
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D220-20160331
980 _ _ |a I:(DE-He78)D200-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21